Pre-registration for this program is complete but you can still register on site to attend this exciting event. Otherwise, the program will be available by mid April 2010, on theheart.org.
Sunday, March 14, 2010
7:00 PM – 9:00 PM
Sheraton Atlanta
165 Courtland Street NE
Atlanta, Georgia
Salon B
Sunday, March 14, 2010
7:00 PM – 9:00 PM
Sheraton Atlanta
165 Courtland Street NE
Atlanta, Georgia
Salon B
DISCLAIMER
This event is not part of the official ACC Annual Scientific Session and/or the ACC's Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation, as planned by their Program Committees.
AGENDA
TARGET AUDIENCE
The program is designed for interventional cardiologists, cardiologists, surgeons, and other physicians involved in the care of patients with complex coronary artery lesions.
EDUCATIONAL OBJECTIVES
After completing the program, the participant will be able to:
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
For questions or assistance, please contact CME@medscape.net.
COMMERCIAL SUPPORT ACKNOWLEDGEMENT
This educational activity is supported by an unrestricted educational grant from
This event is not part of the official ACC Annual Scientific Session and/or the ACC's Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation, as planned by their Program Committees.
AGENDA
| 7:00 pm – 7:20 pm | Introduction: Challenges to New Device Access: An Overview of Issues Dean J. Kereiakes, MD |
| 7:20 pm – 7:40 pm | Optimal Coronary Revascularization in 2010 Ted E. Feldman, MD |
| 7:40 pm – 8:00 pm | Balancing Innovation vs Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD |
| 8:00 pm – 8:20 pm | The Dilemma of Outsourcing Clinical Research Anthony N. DeMaria, MD |
| 8:20 pm – 8:40 pm | New Paradigms for Collaborative Research Infrastructure -- Ramifications for Pre- and Post-market Device Evaluation Mitchell W. Krucoff, MD |
| 8:40 pm – 9:00 pm | Panel Discussion and Question Period |
TARGET AUDIENCE
The program is designed for interventional cardiologists, cardiologists, surgeons, and other physicians involved in the care of patients with complex coronary artery lesions.
EDUCATIONAL OBJECTIVES
After completing the program, the participant will be able to:
- Discuss how new and emerging stent technologies have evolved and their potential to improve patient outcomes
- Identify regulatory approaches to trial design for new stent technology in order to assure patient safety
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
For questions or assistance, please contact CME@medscape.net.
COMMERCIAL SUPPORT ACKNOWLEDGEMENT
This educational activity is supported by an unrestricted educational grant from
CHAIR
Dean J. Kereiakes, MDMedical Director
The Christ Hospital Heart and Vascular Center
The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital
Professor of Clinical Medicine
Ohio State University
Cincinnati, Ohio
FACULTY
Anthony N. DeMaria, MDJudith and Jack White Chair in Cardiology
Professor of Medicine Director
Sulpizio Family Cardiovascular Center
San Diego, California
Ted E. Feldman, MD
Director
Cardiac Catheterization Laboratory Evanston Hospital
Evanston, Illinois
Mitchell W. Krucoff, MD
Professor of Medicine/Cardiology
Duke University Medical Center
Director, CV Devices Unit
Director, eECG Core Lab
Duke Clinical Research Institute
Durham, North Carolina
Bram Zuckerman, MD
Director,
FDA Division of Cardiovascular Devices
Rockville, Maryland
